Camosunate Junior (7-13 years) is an anti-malaria drug that contains artesunate and amodiaquine as its active pharmaceutical ingredient. It is indicated for the treatment of acute uncomplicated malaria attacks, including multi drug resistant strains of Plasmodium falciparum. It comes in a blister of 6 tablets containing 3 white Artesunate tablets and 3 yellow Amodiaquine tablets. Each white tablet contains artesunate 100 mg. Each yellow tablet contains Amodiaquine 300 mg.
